VIDEOS
3:04
ILDPPF||ILDTalks PPF in iNSIP EP.5: How has nintedanib affected our treatment of patients?
3:14
ILDPPF||ILDTalks PPF in HP EP.1: Hypersensitivity pneumonitis: a distinct form of ILD?
4:12
ILDPPF||ILDTalks PPF in CTD-ILD EP.2: How do we monitor patients with CTD-ILD?
2:54
ILDPPF||ILDTalks PPF in HP EP.7: What does the future of HP treatment look like?
3:43
ILDPPF||ILDTalks PPF in CTD-ILD EP.3: Treatment of patients with PPF and CTD-ILD
3:37